Valuation: Jianmin Pharmaceutical Group Co.,Ltd.

Market Cap 3.99B 598M 533M 493M 446M 841M 56.41B 851M 5.91B 2.32B 29.65B 2.24B 2.2B 94.49B P/E 2024
17.5x
P/E 2025 14.2x
Enterprise Value 2.91B 436M 389M 360M 326M 614M 41.17B 621M 4.32B 1.69B 21.64B 1.64B 1.6B 68.96B EV / Sales 2024
1.56x
EV / Sales 2025 1.21x
Free-Float
66.4%
Yield 2024
2.16%
Yield 2025 2.68%
1 day+0.22%
1 week+0.93%
Current month+1.41%
1 month-1.23%
3 months-4.62%
6 months-17.00%
Current year-18.86%
1 week 27.05
Extreme 27.05
27.99
1 month 26.51
Extreme 26.51
27.99
Current year 24.68
Extreme 24.68
35.87
1 year 24.68
Extreme 24.68
40.3
3 years 24.68
Extreme 24.68
72.3
5 years 24.68
Extreme 24.68
86.78
10 years 13.69
Extreme 13.69
86.78
Manager TitleAgeSince
President 50 2020-09-08
Director of Finance/CFO 54 2018-01-01
Compliance Officer 38 -
Director TitleAgeSince
Chairman 39 2019-09-16
Director/Board Member 55 2011-08-02
Director/Board Member 55 2013-09-05
Date Insider Type Main position Quantity % Market Cap. Importance
12/13/21 Sell

Chairman

5,000 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+0.22%+0.93%-32.72%-53.67% 626M
+2.51%+4.38%+60.80%+126.55% 1,133B
+2.13%+3.97%+36.49%+73.95% 621B
-0.30%+0.54%+24.60%+96.87% 503B
-0.36%+2.55%+38.82%+63.92% 379B
+1.71%+5.33%+74.56%+47.97% 370B
+1.51%+2.29%+22.81%+52.40% 292B
+2.01%+1.18%+2.46%+27.21% 262B
+1.64%+3.03%+51.09%+63.77% 237B
+1.06%-0.75%+28.59%+101.38% 190B
Average +1.29%+2.95%+30.75%+60.04% 398.86B
Weighted average by Cap. +1.58%+3.73%+42.89%+84.45%

Financials

2024 2025
Net sales 3.5B 525M 468M 433M 392M 738M 49.54B 747M 5.19B 2.04B 26.04B 1.97B 1.93B 82.97B 3.37B 505M 450M 416M 377M 710M 47.63B 718M 4.99B 1.96B 25.03B 1.89B 1.85B 79.77B
Net income 362M 54.24M 48.34M 44.75M 40.5M 76.3M 5.12B 77.2M 537M 211M 2.69B 203M 199M 8.57B 360M 53.89M 48.02M 44.46M 40.24M 75.81M 5.09B 76.71M 533M 209M 2.67B 202M 198M 8.52B
Net Debt -942M -141M -126M -116M -105M -198M -13.31B -201M -1.4B -547M -7B -529M -518M -22.29B -1.08B -161M -144M -133M -121M -227M -15.24B -230M -1.6B -627M -8.01B -606M -593M -25.52B
Projected Income Statement - Annual - Jianmin Pharmaceutical Group Co.,Ltd.
Logo Jianmin Pharmaceutical Group Co.,Ltd.
Jianmin Pharmaceutical Group Co Ltd, formerly Wuhan Jianmin Pharmaceutical Groups Co Ltd, is a China-based company principally engaged in the research and development, manufacturing, wholesale and retail of pharmaceuticals. The Company operates its businesses through two segments. The Pharmaceutical Production and Sales segment is primarily engaged in the production of various types of Chinese patent medicines and sales to pharmaceutical distributors at all levels, including sales to the commercial division within the group that sells to non-hospitals. The Commercial segment is primarily engaged in the purchase of drugs from manufacturers and manufacturers' agents, and then distribution to lower-level distributors, sales to hospitals and retail sales in pharmacies. The Company mainly operates its businesses in the domestic market.
Employees
2,257
Date Price Change Volume
26-10-22 CN¥26.02 -4.48% 2,028,562
26-10-21 CN¥27.24 +0.22% 1,207,100
26-10-20 CN¥27.18 -2.12% 1,419,000
26-10-19 CN¥27.77 +1.42% 1,695,661
26-10-16 CN¥27.38 +1.11% 1,654,300

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Jianmin Pharmaceutical Group Co.,Ltd.
  1. Stock Market
  2. Stocks
  3. 600976 Stock